Search for: "DEPOMED, INC."
Results 1 - 20
of 25
Sort by Relevance
|
Sort by Date
11 Dec 2023, 7:43 am
Cir. 2018) and In re Depomed Pat. [read post]
31 Jan 2023, 7:44 am
., Inc. v. [read post]
State of NJ Sues a NJ Based Opioid Manufacturer Seeking Reimbursement of Workers' Compensation Costs
13 Nov 2018, 4:17 pm
Grewal announced today that the State has submitted for filing a five-count lawsuit against Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, for deceiving consumers about the dangers of two of the company’s opioid products with high potential for abuse – Nucynta and Nucynta ER. [read post]
30 Apr 2018, 8:46 am
Andrei Iancu, No. 16-1526 Depomed, Inc. v. [read post]
5 Sep 2017, 5:09 pm
Depomed: The first of these investor lawsuits against opioid drug companies was filed on August 18, 2017, when a plaintiff shareholder filed a securities class action lawsuit in the Northern District of California against Depomed, Inc. and three of its current and former officers. [read post]
16 Jun 2017, 6:02 am
Aeroquip Corp., 713 F.2d 1530, 1538 (Fed.Cir. 1983); In re Depomed, Inc., No. 2016-1378, 2017 WL676604, at *5 (Fed. [read post]
8 Mar 2017, 9:59 pm
By Donald Zuhn -- Last month, in In re Depomed, Inc., the Federal Circuit affirmed the determination by the U.S. [read post]
21 Nov 2016, 6:58 am
" Depomed, Inc. v. [read post]
27 Mar 2016, 9:59 pm
Depomed, reviewing the decision of the Patent Trial and Appeal Board on three related inter partes reviews. [read post]
24 Mar 2016, 10:43 am
Depomed, Inc., No. [read post]
3 Oct 2014, 9:55 pm
Paul Simboli of Depomed, Inc. will moderate a panel including Patty McDermott of the U.S. [read post]
28 Aug 2014, 7:28 am
" Depomed, Inc. v. [read post]
15 Jul 2014, 7:10 am
" Depomed, Inc. v. [read post]
21 Apr 2013, 9:54 pm
Depomed, Inc. v. [read post]
26 Apr 2012, 9:18 pm
Depomed Inc. et al. v. [read post]
8 Nov 2011, 4:04 am
” Marketed by Depomed, Inc., GRALISE will gain market share. [read post]
29 Jun 2011, 3:34 am
Apotex Inc. et al. [read post]
22 Jun 2011, 4:09 am
A-G’s opinion published – Merck & Co Inc. v Deutsches Patent- und Markenamt (EPLAW) (The SPC Blog) US: Supreme Court to revisit patentable subject matter eligibility of medical diagnostic methods: Mayo v Prometheus (Patently-O) (Patent Baristas) (PharmaPatents) (IPBiz) (Patent Law Practice Center) US: Intellectual property problems for personalized medicine (BIOtechNow) US: Supreme Court ruling in Stanford v Roche (IPKat) (IPKat) US: Manager’s Amendment (and… [read post]
21 Jun 2010, 8:19 am
Depomed Inc. has suspended all shipments of the 500 mg product. [read post]
19 Jun 2010, 1:19 pm
Drug developer Depomed Inc said it will recall 52 lots of its diabetes drug Glumetza due to the presence of traces of a certain chemical in the tablet's 500 mg bottle.The recall followed an investigation of a single product complaint of a smell and taste consistent with the chemical, the company said in a regulatory filing.The chemical compound, 2,4,6-tribromoanisole (TBA), can cause temporary, non-serious gastrointestinal upset when present in amounts detectable by… [read post]
